TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Most recently, Anstee et al. found PNPLA3, TM6SF2, GCKR and HSD17B13 to have genome-wide significance on disease severity in NAFLD in an elegantly conducted GWAS study [30].